The Benefits of Early Initiation of Continual Renal Replacement Therapy in Patients With Severe Sepsis

Radovan Uvizl200 enrolled

Overview

The study will evaluate the benefit of early initiation of CRRT in the initial phase of severe sepsis in patients admitted to the ICU. Primary evaluated end-point is 28-day mortality. Secondarily evaluated end-point is length of ICU-stay, length of stay in hospital, duration of mechanical ventilation. There are two groups. One group of participants with early CRRT initiation and another group with late CRRT initiation. Reference group no CRRT.

The aim is to determine the optimal timing of initiation of CRRT with respect to the degree and duration of acute kidney injury (AKI) in ICU patients. The CRRT parameters and the duration of therapy will be monitored, depending on initial biochemical and clinical values of the patient. Part of the study is the follow-up of patients with a 3-month delay.

Study Type

OBSERVATIONAL

Enrollment

200

Conditions

Severe Sepsis

Interventions

renal replacement therapyPROCEDURE

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * reaching criteria of severe sepsis, ICU admission Exclusion Criteria: * pregnant women, younger than 18 years, reaching contraindications for initiation of renal replacement therapy

Outcomes

Primary Outcomes

mortality

yes/no

Time frame: 28 days

Secondary Outcomes

duration of mechanical ventilation

days of mechanical ventilation including weening

Time frame: 28 days

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.